Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)

por Kurokawa, Y, Sugimoto, N, Miwa, H, Tsuda, M, Nishina, S, Okuda, H, Imamura, H, Gamoh, M, Sakai, D, Shimokawa, T, Komatsu, Y, Doki, Y, Tsujinaka, T, Furukawa, H
Publicado 2014

FUNCTIONAL CELL PHENOTYPE INDUCTION WITH TGF-β1 AND COLLAGEN-POLYURETHANE SCAFFOLD FOR ANNULUS FIBROSUS RUPTURE REPAIR

por Du, J., Long, R.G., Nakai, T., Sakai, D., Benneker, L.M., Zhou, G., Li, B., Eglin, D., Iatridis, J.C., Alini, M., Grad, S., Li, Z.
Publicado 2020

Randomised phase II study comparing dose-escalated weekly paclitaxel vs standard-dose weekly paclitaxel for patients with previously treated advanced gastric cancer

por Shitara, K, Yuki, S, Tahahari, D, Nakamura, M, Kondo, C, Tsuda, T, Kii, T, Tsuji, Y, Utsunomiya, S, Ichikawa, D, Hosokawa, A, Ishiguro, A, Sakai, D, Hironaka, S, Oze, I, Matsuo, K, Muro, K
Publicado 2014